Completed EUCTR 2009-011745-94
This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In Belgium ADHD Other
Countries France, United Kingdom, Belgium, ...
Sponsor Shire Pharmaceutical Development Limited
Condition ADHD Terminated NCT00508157
This study was terminated in France, in Switzerland, in Belgium, .... It is testing effects of Aripiprazole Versus Other Atypical Antipsychotics for Schizophrenia.
In Belgium Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries France, Switzerland, Belgium, ...
Sponsor Bristol-Myers Squibb
Condition Schizophrenia Ongoing EUCTR 2018-000821-29
This study is ongoing in the United Kingdom, in Belgium, in Germany, .... It focuses on ADHD.
In Belgium ADHD Other
Countries United Kingdom, Belgium, Germany, ...
Sponsor Takeda Development Center Americas, Inc.
Condition ADHD Completed EUCTR 2010-020951-30
This study is completed in the United Kingdom, in Belgium, in the Netherlands, .... It is testing lisdexamfetamine Dimesylate for ADHD.
In Belgium ADHD Other
Countries United Kingdom, Belgium, Netherlands, ...
Sponsor Shire Pharmaceutical Development Ltd
Condition ADHD Completed EUCTR 2020-003726-23
This study is completed in Belgium, in Germany, in Denmark, .... It is testing iclepertin once daily over 26 week treatment period for Schizophrenia.
In Belgium Schizophrenia Other
Countries Belgium, Germany, Denmark, ...
Sponsor Boehringer Ingelheim Pharma GmbH & Co. KG
Condition Schizophrenia Completed EUCTR 2008-000720-10
This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In Belgium ADHD Other
Countries France, United Kingdom, Belgium, ...
Sponsor Shire Pharmaceutical Development Limited
Condition ADHD Completed EUCTR 2008-000679-90
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
In Belgium ADHD Other
Countries France, United Kingdom, Belgium, ...
Sponsor Shire Pharmaceutical Development Limited
Condition ADHD Completed EUCTR 2008-000908-91
This study is completed in the United Kingdom, in Belgium, in Germany, .... It focuses on Depression.
In Belgium Depression Other
Countries United Kingdom, Belgium, Germany, ...
Sponsor AstraZeneca AB
Condition Depression Completed EUCTR 2019-002704-41
This study is completed in Belgium, in Czechia, in Estonia, .... It focuses on depression.
In Belgium Depression Other
Countries Belgium, Czechia, Estonia, ...
Sponsor H. Lundbeck A/S
Condition Depression Completed EUCTR 2011-002362-21
This study is completed in the United Kingdom, in Belgium, in Sweden, .... It focuses on depression.
In Belgium Depression Other
Countries United Kingdom, Belgium, Sweden, ...
Sponsor H. Lundbeck A/S
Condition Depression Completed EUCTR 2008-001441-26
This study is completed in France, in Belgium, in Germany, .... It is testing Lu AE58054 for schizophrenia.
In Belgium Schizophrenia Other
Countries France, Belgium, Germany, ...
Sponsor H. Lundbeck A/S
Condition Schizophrenia Completed EUCTR 2009-017523-26
This study is completed in Belgium, in Finland, in Sweden, .... It is testing Lu AA21004 (15 and 20 mg/day) for Depression.
In Belgium Depression Other
Countries Belgium, Finland, Sweden, ...
Sponsor H. Lundbeck A/S
Condition Depression